Lv4
420 积分 2023-10-26 加入
Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update
4个月前
已完结
Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes
6个月前
已完结
Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050)
7个月前
已完结
The Recent Advances in Molecular Diagnosis of Soft Tissue Tumors
11个月前
已完结
ALK,ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours
11个月前
已完结
Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement
11个月前
已完结
Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
11个月前
已完结
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
11个月前
已完结
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
11个月前
已完结
Impact of molecular biology in children with ALK+ inflammatory myofibroblastic tumour. A reflexion from a case report
11个月前
已完结
Vaccine Candidate Brucella melitensis 16M ΔvjbR Is Safe in a Pregnant Sheep Model and Confers Protection
皖公网安备34019202002308
